Co-investments for international VCs
Get access to curated Finnish growth rounds, led and structured by Springvest, and ready for co-investment.
Co-invest in world-class Finnish tech
Finland is a European technology leader, with strong digital expertise, high R&D intensity and well-established defence and space sectors.
Springvest gives international VCs direct access to deal flow and co-investment opportunities in promising Finnish growth-stage technology companies across Series A, Series B and pre-IPO rounds.
Up to 10
Rounds per year
Up to €50M
Total funding round size
What you get
Terms and structure, ready to go
As round arranger, we handle due diligence and term sheet negotiations. You focus on the investment decision.
Finnish anchor capital supporting the round
Our private placements are anchored with €5–12 million from over 10,000 Finnish private investors and family offices. Many rounds also include leading Finnish institutional investors.
Listed and regulated
Springvest is listed on Nasdaq First North and authorised by the Finnish Financial Supervisory Authority (FIN-FSA).
We know the Finnish regulatory environment inside out.
Case: ReOrbit: Finland’s largest Series A
In 2025, ReOrbit raised a €45 million Series A to scale its software-first satellite technology for secure government and commercial communications. The round was one of the most significant funding rounds in Europe for a new space company.
Finland is a technology powerhouse
Finland boasts leading digital expertise in Europe, a strong R&D investment intensity relative to GDP, and well-established defence and space technology sectors.
Growth companies in Finland often reach a more advanced stage than their peers elsewhere before seeking international capital. This results in more mature technology and more moderate valuations compared with major Western European hubs.
Public co-financing from Business Finland, VTT Technical Research Centre of Finland and EU programmes further bolsters companies’ capital structure between rounds.
Why Springvest
100% round success rate
Every committed public funding round completed and reached minimum
+10 000 Finnish investors
Anchoring every round
Organiser in every deal
We structure, negotiate and execute
Listed and regulated
FIN-FSA authorised, publicly accountable
Long-term alignment
We stay in as shareholders after every close
Companies we’ve worked with
Desentum develops a new type of immunotherapy for treating allergies, which may help shift from symptom management to treating the disease itself.
ReOrbit designs and manufactures next-generation innovative, software-defined satellites.
Solar Foods commercializes a new food protein, Solein, produced using carbon dioxide and electricity as its primary raw materials.
CurifyLabs uses its technology to automate pharmaceutical compounding in pharmacies and hospital pharmacies.
Get in touch!
We invite professional clients to join the larger financing rounds we lead, either as lead investors or co-investors. Share issues are ongoing continuously. Would you like to hear more?
Contact our team: coinvestor@springvest.fi
Notice to investors
This page is intended for institutional and professional investors and does not constitute investment advice. Investing in unlisted growth companies involves significant risks, including the loss of invested capital. As a publicly listed company, Springvest Corporation complies with Finnish market regulations and is authorised by the Finnish Financial Supervisory Authority (FIN-FSA).